Revance Therapeutics Claimed Company

Revance Therapeutics is a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions. read more

EMPLOYEE PARTICIPANTS: 21

TOTAL RATINGS: 250

CEO: Mark Foley

HR or Marketing? Claim Your Free Employer Account

Revance Therapeutics CEO & Leadership Team Ratings

Mark Foley and the Revance Therapeutics leadership team are scored a D+ by 19 employees placing it in the Bottom 25% of companies sized 51-200 Employees on Comparably. The Leadership score includes details about how employees evaluate their executive team, CEO and manager.

Based on 53 ratings, the Leadership score of 60/100 combines employee feedback on their CEO (59/100), Manager (62/100), and Executive Team (60/100).

Mark Foley Revance Therapeutics CEO Rating

Bottom 20% Compared to other companies of similar size in San Francisco

59 / 100

Mark Foley the CEO of Revance Therapeutics received an average score of 59 from Revance Therapeutics employees.

Male employees at Revance Therapeutics rate the CEO the highest.

Male: 86

Female:

Revance Therapeutics Manager Rating

Bottom 25% Compared to other companies of similar size in San Francisco

D+

62 / 100

Managers received an average score of 62 from Revance Therapeutics employees.

Male employees at Revance Therapeutics rate their Manager the highest.

Male: 85

Female:

Revance Therapeutics Executive Team Rating

Bottom 25% Compared to other companies of similar size in San Francisco

D+

60 / 100

The Executive team received an average score of 60 from Revance Therapeutics employees.

Rate your company